述评(Commentary)

ASCO、NCCN临床实践指南关于可切除及可能切除胰腺癌诊治的共识与争议

Published at: 2017年第26卷第9期

郑苏丽 1 , 张太平 1
1 北京协和医院 外科,北京 100032
通讯作者 太平 张 Email: andrewzhangt@aliyun.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.09.001
基金:

摘要

胰腺癌是消化系统预后最差的恶性肿瘤之一,如何科学、规范地治疗胰腺癌一直是外科领域的热点问题。笔者围绕ASCO指南中的“潜在可治愈胰腺癌”和NCCN指南中的“可切除和可能切除的胰腺癌”治疗策略异同点进行讨论,主要包括初步评估、手术适应证、术前治疗、术后治疗、随访监测5个方面。


Consensus and controversy about resectable and possibly resectable pancreatic cancer between ASCO and NCCN clinical practice guideline

Abstract

Pancreatic cancer is one of the digestive malignancies with the worst prognosis and therefore, how to provide scientific and standard treatment for pancreatic cancer is a hot topic in the field of surgery. In this article, the authors discuss the similarities and differences in the treatment strategies between the “potentially curable pancreatic cancer” in the ASCO guideline and the “resectable and borderline resectable pancreatic cancer” in the NCCN guideline from five aspects: preliminary assessment, surgical indications, preoperative management, postoperative treatment and follow-up surveillance.


comments powered by Disqus

全文

引用

引用本文: 苏丽 郑, 太平 张. ASCO、NCCN临床实践指南关于可切除及可能切除胰腺癌诊治的共识与争议[J]. 中国普通外科杂志, 2017, 26(9): 1085-1088.
Cite this article as: ZHENG Suli, ZHANG Taiping . Consensus and controversy about resectable and possibly resectable pancreatic cancer between ASCO and NCCN clinical practice guideline [J]. Chin J Gen Surg, 2017, 26(9): 1085-1088.